Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chemotherapy-Induced Peripheral Neuropathy × Cannabidiol × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Other 1

Conditions

Tuberous Sclerosis 3 Seizures 2 Lennox Gastaut Syndrome 2 Epilepsies, Myoclonic 2 Liver Cirrhosis 1 Glioblastoma 1 Chemotherapy-Induced Peripheral Neuropathy 1 Cancer Pain 1 Behavior 1

Interventions

Standard of Care 1 Spinal Cord Stimulation 1 Specimen Handling 1 Practice Guidelines as Topic 1 Methods 1 Massage 1 Interviews as Topic 1 Educational Status 1 Early Intervention, Educational 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05388058 2026-01-16

Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

Mayo Clinic

Phase 2 Completed

40 enrolled 15 charts

OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡